Shock
Shock
Explore linked clinical trials. Standard reference: MESH:M0019782486 results · Page 1 of 20
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| French Observatory on the Management of Cardiogenic Shock 2 | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Not yet recruiting | Not stated | 2026-10-09 | NCT07868757 | |
| Immune Dysregulation During Sepsis: A Natural History Cohort | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-09 | NCT07735741 | |
| Remote Ischemic Postconditioning in Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-10-09 | NCT07273942 | |
| Validation of the iCVS Model in Patients Admitted to the Intensive Care Unit | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock | Not yet recruiting | Not stated | 2026-10-09 | NCT07256886 | |
| Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Inflammation, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-10-09 | NCT06806033 | |
| HOPE-Sepsis: Hemoadsorption Therapy for Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not applicable | 2026-10-08 | NCT07865585 | |
| Sepsis ICU Gut Microbiome Analysis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-08 | NCT07864818 | |
| Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-08 | NCT06531031 | |
| Non-invasive Hemodynamic Optimization of Sepsis in Internal Medicine: a Randomized Study Comparing Therapy Guided by Non-invasive Hemodynamic Indices Versus Standard of Care. | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-07 | NCT07863323 | |
| Plasma Exchange in Children With Severe Sepsis and Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Severe Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-07 | NCT07706413 | |
| Effect of Targeting Upper Normal Serum Magnesium Levels on Norepinephrine Requirements in Septic Shock Patients | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-06 | NCT07716956 | |
| Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Inflammation, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Systemic Inflammatory Response Syndrome, cardiovascular disorder, cytokine release syndrome, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-10-06 | NCT07657312 | |
| Dynamic SvO2 in Predicting Fluid Responsiveness in Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not stated | 2026-10-06 | NCT07516236 | |
| Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Not applicable | 2026-10-06 | NCT06140147 | |
| pSOFA Score in Predicting Mortality in Pediatric Intensive Care | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome | Not yet recruiting | Not stated | 2026-10-05 | NCT07858487 | |
| Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury Receiving Continuous Renal Replacement Therapy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not applicable | 2026-10-05 | NCT07346118 | |
| Prognostic Value of Stress Hyperglycemia Ratio in Critically Ill Patients | Critical Illness, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Urogenital Diseases, acute kidney injury, glucose metabolism disease, hyperglycemia, kidney disorder, kidney failure, metabolic disease, multiple organ dysfunction syndrome, urinary system disorder | Not yet recruiting | Not stated | 2026-10-02 | NCT07853911 | |
| Predictors of In-Hospital Mortality in Severe Abdominal Trauma | Abdominal Injuries, Hemorrhage, Multiple Trauma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Hemorrhagic, Wounds, Nonpenetrating, Wounds, Penetrating, injury | Recruiting | Not stated | 2026-10-02 | NCT07843628 | |
| CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia | Disease Attributes, Hemic and Lymphatic Diseases, Inflammation, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Shock, Systemic Inflammatory Response Syndrome, acute myeloid leukemia, cytokine release syndrome, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 | 2026-10-02 | NCT07841002 | |
| Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities on Patient Outcomes After Invasive Mechanical Ventilation and Vasopressor Therapy in the ICU | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock | Recruiting | Not applicable | 2026-10-02 | NCT06581939 | |
| Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Active, not recruiting | Not stated | 2026-10-01 | NCT06654895 | |
| Development and Internal Validation of a Multimodal Prediction Score for Early Hemodynamic Deterioration in Adult Polytrauma Patients | Disease Attributes, Emergencies, Hemorrhage, Multiple Trauma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Traumatic, injury | Not yet recruiting | Not stated | 2026-09-30 | NCT07850427 | |
| Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study | Disease Attributes, Emergencies, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Active, not recruiting | Not stated | 2026-09-29 | NCT07425587 | |
| Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic Shock | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-09-29 | NCT07345559 | |
| CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemorrhage, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Hemorrhagic, Urogenital Diseases, diabetes insipidus, endocrine system disorder, injury, kidney disorder, pituitary gland disorder, urinary system disorder | Recruiting | Phase 2 | 2026-09-29 | NCT05958342 |